Baillie Gifford UK Growth Trust (BGUK) Competitors GBX 203 -1.00 (-0.49%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BGUK vs. BPCR, BRWM, GSS, TRY, JPE, BBGI, TMPL, OCI, APAX, and ICGTShould you be buying Baillie Gifford UK Growth Trust stock or one of its competitors? The main competitors of Baillie Gifford UK Growth Trust include BioPharma Credit (BPCR), BlackRock World Mining Trust (BRWM), Genesis Emerging Markets Fund (GSS), TR Property Investment Trust (TRY), JPMorgan Elect plc - Managed Growth (JPE), BBGI Global Infrastructure (BBGI), Temple Bar (TMPL), Oakley Capital Investments (OCI), Apax Global Alpha (APAX), and ICG Enterprise Trust (ICGT). These companies are all part of the "asset management" industry. Baillie Gifford UK Growth Trust vs. Its Competitors BioPharma Credit BlackRock World Mining Trust Genesis Emerging Markets Fund TR Property Investment Trust JPMorgan Elect plc - Managed Growth BBGI Global Infrastructure Temple Bar Oakley Capital Investments Apax Global Alpha ICG Enterprise Trust Baillie Gifford UK Growth Trust (LON:BGUK) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership. Is BGUK or BPCR a better dividend stock? Baillie Gifford UK Growth Trust pays an annual dividend of GBX 6 per share and has a dividend yield of 3.0%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 776.1%. Baillie Gifford UK Growth Trust pays out 15.4% of its earnings in the form of a dividend. BioPharma Credit pays out 7,957.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Does the media refer more to BGUK or BPCR? In the previous week, Baillie Gifford UK Growth Trust's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score. Company Overall Sentiment Baillie Gifford UK Growth Trust Neutral BioPharma Credit Neutral Which has higher valuation & earnings, BGUK or BPCR? BioPharma Credit has higher revenue and earnings than Baillie Gifford UK Growth Trust. Baillie Gifford UK Growth Trust is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaillie Gifford UK Growth Trust£56.32M4.90£53.08M£39.025.20BioPharma Credit£12.99B0.08£10.42B£0.0910.25 Do institutionals and insiders believe in BGUK or BPCR? 45.0% of Baillie Gifford UK Growth Trust shares are held by institutional investors. Comparatively, 41.5% of BioPharma Credit shares are held by institutional investors. 3.2% of Baillie Gifford UK Growth Trust shares are held by company insiders. Comparatively, 6.2% of BioPharma Credit shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is BGUK or BPCR more profitable? Baillie Gifford UK Growth Trust has a net margin of 94.25% compared to BioPharma Credit's net margin of 80.20%. Baillie Gifford UK Growth Trust's return on equity of 19.81% beat BioPharma Credit's return on equity.Company Net Margins Return on Equity Return on Assets Baillie Gifford UK Growth Trust94.25% 19.81% 0.31% BioPharma Credit 80.20%8.51%4.98% Which has more risk & volatility, BGUK or BPCR? Baillie Gifford UK Growth Trust has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, BioPharma Credit has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. SummaryBaillie Gifford UK Growth Trust beats BioPharma Credit on 7 of the 13 factors compared between the two stocks. Get Baillie Gifford UK Growth Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for BGUK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGUK vs. The Competition Export to ExcelMetricBaillie Gifford UK Growth TrustAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£275.76M£1.30B£6.49B£3.18BDividend Yield2.87%4.41%4.17%5.04%P/E Ratio5.2022.5614.27165.81Price / Sales4.902,438.741,766.21450,162.38Price / Cash167.0060.62127.5027.93Price / Book1.021.395.286.36Net Income£53.08M£265.04M£1.23B£5.89B7 Day Performance1.00%0.30%0.92%0.92%1 Month Performance-0.98%0.78%2.21%49.65%1 Year Performance14.37%6.41%24.62%131.94% Baillie Gifford UK Growth Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGUKBaillie Gifford UK Growth TrustN/AGBX 203-0.5%N/A+15.9%£275.76M£56.32M5.20N/ANews CoverageBPCRBioPharma CreditN/AGBX 0.91+1.9%N/A-3.2%£1.08B£12.99B10.31N/ABRWMBlackRock World Mining TrustN/AGBX 560.55+1.0%N/A+6.6%£1.07B£8.73M-80.19147,000GSSGenesis Emerging Markets FundN/AN/AN/AN/A£1.06B£250.40M6.181,626Gap DownTRYTR Property Investment TrustN/AGBX 325.50-0.6%N/A-4.5%£1.03B£311.14M3.6426Positive NewsJPEJPMorgan Elect plc - Managed GrowthN/AN/AN/AN/A£1.00B£104.78M1,250.00N/ABBGIBBGI Global InfrastructureN/AGBX 138.50flatN/AN/A£984.71M£67.98M17.931,160TMPLTemple BarN/AGBX 343-0.9%N/A+26.4%£981.26M£157.64M6.37N/AEarnings ReportOCIOakley Capital InvestmentsN/AGBX 554.99-0.2%N/A+6.1%£979.07M£99.08M11.12N/AAPAXApax Global AlphaN/AGBX 163.80+0.1%N/A+10.0%£956.37M£9.05M277.90N/AICGTICG Enterprise TrustN/AGBX 1,468+0.8%N/A+14.8%£948.75M£55.63M29.31N/APositive News Related Companies and Tools Related Companies BioPharma Credit Alternatives BlackRock World Mining Trust Alternatives Genesis Emerging Markets Fund Alternatives TR Property Investment Trust Alternatives JPMorgan Elect plc - Managed Growth Alternatives BBGI Global Infrastructure Alternatives Temple Bar Alternatives Oakley Capital Investments Alternatives Apax Global Alpha Alternatives ICG Enterprise Trust Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BGUK) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baillie Gifford UK Growth Trust plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Baillie Gifford UK Growth Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access